576 related articles for article (PubMed ID: 19031056)
21. Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain.
López-Bastida J; Perestelo-Pérez L; Montón-Alvarez F; Serrano-Aguilar P; Alfonso-Sanchez JL
Amyotroph Lateral Scler; 2009 Aug; 10(4):237-43. PubMed ID: 18821088
[TBL] [Abstract][Full Text] [Related]
22. [Depression: a social mortgage. Latest advances in knowledge of the cost of the disease].
Valladares A; Dilla T; Sacristán JA
Actas Esp Psiquiatr; 2009; 37(1):49-53. PubMed ID: 18781410
[TBL] [Abstract][Full Text] [Related]
23. Costs of back pain in Germany.
Wenig CM; Schmidt CO; Kohlmann T; Schweikert B
Eur J Pain; 2009 Mar; 13(3):280-6. PubMed ID: 18524652
[TBL] [Abstract][Full Text] [Related]
24. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
Rotstein Z; Hazan R; Barak Y; Achiron A
Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
[TBL] [Abstract][Full Text] [Related]
25. Health economics and cost implications of anxiety and other mental disorders in the United States.
Rice DP; Miller LS
Br J Psychiatry Suppl; 1998; (34):4-9. PubMed ID: 9829010
[TBL] [Abstract][Full Text] [Related]
26. Cost estimates of brain disorders in Belgium.
Schoenen J; Gianni F; Schretlen L; Sobocki P
Acta Neurol Belg; 2006 Dec; 106(4):208-14. PubMed ID: 17323838
[TBL] [Abstract][Full Text] [Related]
27. The societal burden of osteoporosis in Sweden.
Borgström F; Sobocki P; Ström O; Jönsson B
Bone; 2007 Jun; 40(6):1602-9. PubMed ID: 17433804
[TBL] [Abstract][Full Text] [Related]
28. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
[TBL] [Abstract][Full Text] [Related]
29. The costs of schizophrenia.
McEvoy JP
J Clin Psychiatry; 2007; 68 Suppl 14():4-7. PubMed ID: 18284271
[TBL] [Abstract][Full Text] [Related]
30. [The cost of illness].
van Roijen L; Koopmanschap MA; Bonneux L
Ned Tijdschr Geneeskd; 1992 Jan; 136(2):74-80. PubMed ID: 1732831
[TBL] [Abstract][Full Text] [Related]
31. Cost of disorders of the brain in Ireland.
McHugh JC; Murphy RP; Sobocki P
Ir Med J; 2007; 100(7):518-21. PubMed ID: 17886523
[TBL] [Abstract][Full Text] [Related]
32. Social economic costs and health-related quality of life in patients with degenerative cerebellar ataxia in Spain.
López-Bastida J; Perestelo-Pérez L; Montón-Alvarez F; Serrano-Aguilar P
Mov Disord; 2008 Jan; 23(2):212-7. PubMed ID: 17999424
[TBL] [Abstract][Full Text] [Related]
33. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan.
Yang MC; Fann CY; Wen CP; Cheng TY
Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i62-70. PubMed ID: 15923452
[TBL] [Abstract][Full Text] [Related]
34. A cross-national perspective on cost of illness: a comparison of studies from The Netherlands, Australia, Canada, Germany, United Kingdom, and Sweden.
Polder JJ; Meerding WJ; Bonneux L; van der Maas PJ
Eur J Health Econ; 2005 Sep; 6(3):223-32. PubMed ID: 15856350
[TBL] [Abstract][Full Text] [Related]
35. The total costs of illness: a metric for health care reform.
Gustafson DH; Helstad CP; Hung CF; Nelson G; Batalden P
Hosp Health Serv Adm; 1995; 40(1):154-71. PubMed ID: 10172238
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease: the burden of the illness in England.
Gray A; Fenn P
Health Trends; 1993; 25(1):31-7. PubMed ID: 10171428
[TBL] [Abstract][Full Text] [Related]
37. Injury rate and socioeconomic costs resulting from sports injuries in Flanders: data derived from sports insurance statistics 2003.
Cumps E; Verhagen E; Annemans L; Meeusen R
Br J Sports Med; 2008 Sep; 42(9):767-72. PubMed ID: 18048438
[TBL] [Abstract][Full Text] [Related]
38. [The cost of arterial hypertension in Spain].
Badía X; Rovira J; Tresserras R; Trinxet C; Segú JL; Pardell H
Med Clin (Barc); 1992 Dec; 99(20):769-73. PubMed ID: 1369787
[TBL] [Abstract][Full Text] [Related]
39. The importance of considering non-monetary costs and benefits in selecting pharmacologic interventions in mental health.
Pleil AM
Psychopharmacol Bull; 1995; 31(4):727-34. PubMed ID: 8851646
[TBL] [Abstract][Full Text] [Related]
40. Household costs of mental health care in Ghana.
Addo R; Nonvignon J; Aikins M
J Ment Health Policy Econ; 2013 Dec; 16(4):151-9. PubMed ID: 24526584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
